Nwe N. Than

Coventry, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications

The use of pharmacotherapies in non-cirrhotic metabolic dysfunction-associated steatohepatitis: a UK expert consensus.

The use of pharmacotherapies in non-cirrhotic metabolic dysfunction-associated steatohepatitis: a UK expert consensus.

Journal: The lancet. Gastroenterology & hepatology
Published: December 21, 2025

Cardiovascular Disease in the Context of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Comprehensive Narrative Review.

Cardiovascular Disease in the Context of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Comprehensive Narrative Review.

Journal: International journal of molecular sciences
Published: September 27, 2025

Circulating angiopoietin-like protein 8 (ANGPTL8) and steatotic liver disease related to metabolic dysfunction: an updated systematic review and meta-analysis.

Circulating angiopoietin-like protein 8 (ANGPTL8) and steatotic liver disease related to metabolic dysfunction: an updated systematic review and meta-analysis.

Journal: Frontiers in endocrinology
Published: February 11, 2025

Current Surveillance Strategy Is Less Effective for Detecting Early-Stage Hepatocellular Carcinoma in Patients with Non-Viral and Non-Cirrhotic Liver Disease.

Current Surveillance Strategy Is Less Effective for Detecting Early-Stage Hepatocellular Carcinoma in Patients with Non-Viral and Non-Cirrhotic Liver Disease.

Journal: Liver cancer
Published: May 22, 2024

Poor correlation of 2D shear wave elastography and transient elastography in Fontan-associated liver disease: A head-to-head comparison.

Poor correlation of 2D shear wave elastography and transient elastography in Fontan-associated liver disease: A head-to-head comparison.

Journal: JGH open : an open access journal of gastroenterology and hepatology
Published: March 19, 2023

The Fatty Liver, Cirrhosis, and Liver Cancer Study (TENDENCY): Protocol for a Multicenter Case-Control Study.

The Fatty Liver, Cirrhosis, and Liver Cancer Study (TENDENCY): Protocol for a Multicenter Case-Control Study.

Journal: JMIR research protocols
Published: November 22, 2022

Steroid-refractory T-cell mediated rejection after human metapneumovirus infection in a liver transplant recipient.

Steroid-refractory T-cell mediated rejection after human metapneumovirus infection in a liver transplant recipient.

Journal: Pathology
Published: September 08, 2020

An Unusual Case of Hematochezia.

An Unusual Case of Hematochezia.

Journal: Cureus
Published: August 09, 2020

Acute Confusion Following Liver Transplantation: HE or Not HE, That Is the Question.

Acute Confusion Following Liver Transplantation: HE or Not HE, That Is the Question.

Journal: Hepatology (Baltimore, Md.)
Published: April 22, 2020

Efficacy of rituximab in difficult-to-manage autoimmune hepatitis: Results from the International Autoimmune Hepatitis Group.

Efficacy of rituximab in difficult-to-manage autoimmune hepatitis: Results from the International Autoimmune Hepatitis Group.

Journal: JHEP reports : innovation in hepatology
Published: May 20, 2019

Corrigendum to "Autoimmune Hepatitis: Progress from Global Immunosuppression to Personalised Regulatory T Cell Therapy".

Corrigendum to "Autoimmune Hepatitis: Progress from Global Immunosuppression to Personalised Regulatory T Cell Therapy".

Journal: Canadian journal of gastroenterology & hepatology
Published: September 22, 2016

Sphingosine-1-Phosphate Prevents Egress of Hematopoietic Stem Cells From Liver to Reduce Fibrosis.

Sphingosine-1-Phosphate Prevents Egress of Hematopoietic Stem Cells From Liver to Reduce Fibrosis.

Journal: Gastroenterology
Published: July 12, 2016
Showing 1-12 of 23

Last Updated: 09/26/2026